Prof. Gonzalo Calvo, Spain
Prof. Calvo’s main area of expertise is drug regulation, with particular interest in cardiovascular and onco-haematology. He has been principal investigator of around 50 clinical trials and has co-authored 85 peer-reviewed papers and 2 books.
From 2002 to 2011, he represented the Spanish Agency on Medicines and Healthcare Products (AEMPS) at the EMA Committee for Human Medicinal Products (CHMP) as rapporteur of more than 60 new drug applications.
Prof. Calvo has been the chair of the CHMP Cardiovascular Working Party since 2002.
He was elected President of the European Association of Clinical Pharmacology and Therapeutics (EACPT) in 2011.
Gonzalo Calvo Rojas
Updated on 2015-06-30T13:25:25+00:00, by .